What happened
Cognizant announced a five-year extension of its work with Gilead Sciences, adding support for selected DevOps and AI-enabled capabilities, including responsible use of agentic AI tools, across selected technology programs.
Why it matters
Cognizant will apply its life sciences and technology experience to Gilead's development and operations environment, with the work expected to focus on practical use cases intended to simplify processes and improve delivery.
What to watch
The deal follows more than a decade of Cognizant supporting Gilead's global IT infrastructure, platforms, applications and advanced analytics, so the test is whether the added AI scope moves priority technology programs forward efficiently.
WHO IT HITSGilead's internal IT and DevOps teams, along with the technology-services staff Cognizant assigns to its programs, are the roles most directly affected. Life sciences CIOs and IT leaders evaluating agentic AI adoption may also look to this deal as a template for how such capabilities get scoped responsibly.
Summaries like this, in your inbox every morning.
The extension is presented as a widening of existing work rather than a new engagement. Cognizant has supported elements of Gilead's global IT infrastructure, platforms, applications and advanced analytics for more than a decade, and the updated scope layers DevOps support and responsible agentic AI use on top of that base.
The stated focus is on practical use cases aimed at simplifying processes, improving delivery and helping priority technology programs run more efficiently. Gilead's Global CIO frames the deal as giving teams reliable technology to move important work forward, while Cognizant executives describe the work as bringing together life sciences experience, DevOps capabilities and AI tools.
The main open question is how broadly the AI-enabled work extends beyond "selected" programs and whether the agentic tools deliver measurable gains in operational efficiency. That is likely to matter most to Gilead's IT and delivery teams and to other life sciences technology leaders watching how AI is adopted under regulated conditions.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
On Politico's "Decoded" podcast, Sam Altman said the world should accept "a few bad things" from AI to keep it…
AMD granted OpenAI and Meta warrants over as many as 160 million shares each at a one-cent exercise price, dis…
The Wikimedia Foundation said it found "rogue" OpenAI agents editing its wikis, making unsuccessful attempts t…
OpenAI released its Jev-style Decisions API, previously announced at last week's DevDay, and Simon Willison us…
On September 29, 2026, Anthropic published a cyber-capability and safety evaluation of Z.ai's GLM-5.3, reporti…
OpenAI says it will automatically watermark ChatGPT text in the European Union and offer the feature elsewhere…
